We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1301:TWSEFormosa Plastics Corporation Analysis

Data as of 2026-06-13 - not real-time

NT$45.25

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 45.25 TWD, which sits below its 20‑day and 50‑day simple moving averages but remains above the 200‑day average, indicating a short‑term pullback within a longer‑term uptrend. RSI at 43 suggests neutral momentum, while the MACD histogram is negative and the signal line is bearish, reinforcing downside pressure. Volume has been increasing, supporting the recent price action, yet the 30‑day volatility of roughly 39% and a beta of 0.37 point to a stock that can swing sharply while being less correlated with the broader market. The market sentiment is extremely bullish, as reflected by a fear‑greed index of 89.86, but price is still far from the identified resistance near 53.4 TWD and near the support level of 43.1 TWD.
Fundamentally, the company posted an 11% revenue decline and negative gross, operating, and profit margins, with a trailing EPS loss of -1.58 TWD. Forward EPS is projected positive at 1.37 TWD, and analysts have a median price target of 60 TWD, implying upside potential. The balance sheet shows ample cash (133B TWD) but a very high debt load (154B TWD) resulting in a debt‑to‑equity ratio above 39, and free cash flow is negative, raising concerns about dividend sustainability despite a 1.1% yield. Valuation metrics are mixed: a low price‑to‑book of 0.74 suggests relative cheapness, yet the discounted cash‑flow fair value of just 8.1 TWD flags significant overvaluation relative to current price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • High recent volatility
  • Proximity to near‑term support at 43.1 TWD

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets suggesting 15‑30% upside
  • Forward EPS turning positive
  • Low price‑to‑book ratio offering value exposure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong asset base and low PB multiple
  • Potential turnaround in margins as market conditions improve
  • Strategic position in specialty chemicals despite regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-11.10%
Profit Margin-4.01%
P/E Ratio33.0
ROE-2.01%
ROA-0.90%
Debt/Equity39.62
P/B Ratio0.7
Op. Cash FlowNT$7.9B
Free Cash FlowNT$-7135266816

Technical Analysis

TrendNeutral
RSI43.0
SupportNT$43.10
ResistanceNT$53.40
MA 20NT$46.66
MA 50NT$48.57
MA 200NT$43.43
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueNT$8.14
Target PriceNT$52.80
Upside/Downside16.69%
GradeOvervalued
TypeValue
Dividend Yield1.10%

Risk Assessment

Beta0.37
Volatility39.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.